Počet záznamů: 1  

Genetic variants in C-type lectin genes are associated with colorectal cancer susceptibility and clinical outcome

  1. 1.
    SYSNO ASEP0396305
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevGenetic variants in C-type lectin genes are associated with colorectal cancer susceptibility and clinical outcome
    Tvůrce(i) Lu, S. (DE)
    Bevier, M. (DE)
    Huhn, S. (DE)
    Sainz, J. (DE)
    Lascorz, J. (DE)
    Pardini, Barbara (UEM-P)
    Naccarati, Alessio (UEM-P)
    Vodičková, Ludmila (UEM-P) RID
    Novotný, J. (CZ)
    Hemminki, K. (DE)
    Vodička, Pavel (UEM-P) RID
    Försti, A. (DE)
    Celkový počet autorů12
    Zdroj.dok.International Journal of Cancer. - : Wiley - ISSN 0020-7136
    Roč. 133, č. 10 (2013), s. 2325-2333
    Poč.str.9 s.
    Jazyk dok.eng - angličtina
    Země vyd.DE - Německo
    Klíč. slovaCD209 ; colorectal cancer ; polymorphism
    Vědní obor RIVEB - Genetika a molekulární biologie
    CEPGAP304/10/1286 GA ČR - Grantová agentura ČR
    GAP304/12/1585 GA ČR - Grantová agentura ČR
    Institucionální podporaUEM-P - RVO:68378041
    UT WOS000324072300007
    EID SCOPUS84883769767
    DOI10.1002/ijc.28251
    AnotaceInflammatory responses play a vital role at different stages of colorectal carcinogenesis. C-type lectins mediate inflammatory/immune responses and participate in immune escape of pathogens and tumors. Our study aimed to evaluate the correlation between polymorphisms in three C-type lectin genes, CD209, MBL2 and REG4, and colorectal cancer (CRC) risk and clinical outcome. We genotyped 15 potentially functional single nucleotide polymorphisms (SNPs) and assessed their associations with CRC risk in a case-control study of 1353 CRC cases and 767 healthy controls from the Czech Republic. We also analyzed these SNPs in relation to overall and event-free survival in 414 patients. Minor allele carriers of the promoter SNP rs2287886 had an increased risk of CRC (OR 1.30, 95% CI 1.08-1.56), while minor allele carriers of the 3'UTR SNP, rs7248637, had a decreased risk (OR 0.74, 95% CI 0.60-0.91). Multivariate survival analyses, including age, gender, TNM stage and grade, showed that patients without distant metastasis at the time of diagnosis and carrying the rs2994809 T allele had a decreased overall and event-free survival (HR 2.11, 95% CI 1.20-3.72 and HR 2.00, 95% CI 1.18-3.39, respectively). We show that SNPs in CD209 may affect CRC risk, while a SNP in REG4 may be a useful marker for CRC progression.
    PracovištěÚstav experimentální medicíny
    KontaktLenka Koželská, lenka.kozelska@iem.cas.cz, Tel.: 241 062 218, 296 442 218
    Rok sběru2014
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.